Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Myelodysplastic Syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback